Start for free
Start for free
CP

Caligan Partners

North America, New York, United States, New York

Description

Caligan Partners is an investment advisory firm.

Investor Profile

Caligan Partners has made 5 investments, with 1 in the past 12 months and 80% as lead.

Stage Focus

  • Post Ipo Equity (80%)
  • Series A (20%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Therapeutics
  • Health Care
  • Biopharma
  • Nanotechnology
  • Pharmaceutical
  • Manufacturing
  • Medical
  • Medical Device
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Caligan Partners frequently co-invest with?

Altium Capital
Altium Capital
North America, New York, United States, New York
Co-Investments: 1
Innocreative Capital
Innocreative Capital
North America, California, United States, Woodland Hills
Co-Investments: 1
GH
GMS Holdings
Asia, Amman, Jordan, Amman
Co-Investments: 1
Woodline Partners
Woodline Partners
North America, California, United States, San Francisco
Co-Investments: 1
Sphera Global Healthcare Fund
Sphera Global Healthcare Fund
Asia, Tel Aviv, Israel, Tel Aviv
Co-Investments: 1
Great Point Partners
Great Point Partners
North America, Connecticut, United States, Greenwich
Co-Investments: 1
VC
Velan Capital
North America, Georgia, United States, Alpharetta
Co-Investments: 1
Schonfeld Strategic Advisors
Schonfeld Strategic Advisors
North America, New York, United States, New York
Co-Investments: 1
Armistice Capital
Armistice Capital
North America, New York, United States, New York
Co-Investments: 1
SV
Syntone Ventures
North America, North Carolina, United States, Cary
Co-Investments: 1

Which angels does Caligan Partners often collaborate with?

PM
Paul Manning
North America, Virginia, United States, Charlottesville
Shared Deals: 1
RJ
Roger Jeffs
North America, North Carolina, United States, Chapel Hill
Shared Deals: 1

What are some of recent deals done by Caligan Partners?

Liquidia Technologies

Morrisville, North Carolina, United States

Liquidia Technologies is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics.

BiopharmaBiotechnologyHealth CareNanotechnologyTherapeutics
Post Ipo EquitySep 11, 2024
Amount Raised: $67,500,000
Anika Therapeutics

Bedford, Massachusetts, United States

Anika Therapeutics, Inc. develops, manufactures, and commercializes therapeutic products for tissue protection, healing, and repair. Its

BiotechnologyHealth CareManufacturingTherapeutics
Post Ipo EquityMar 7, 2024
Outlook Therapeutics

Iselin, New Jersey, United States

Outlook Therapeutics is a biopharmaceutical company that develops ophthalmic formulations.

BiopharmaBiotechnologyPharmaceuticalTherapeutics
Post Ipo EquityJan 23, 2024
Amount Raised: $65,000,000
Teal Bio

Somerville, Massachusetts, United States

Teal Bio offers a respirator system that is designed to be reusable and easily disinfected.

Health CareMedicalMedical Device
Series ANov 22, 2021
Amount Raised: $3,000,000
Liquidia Technologies

Morrisville, North Carolina, United States

Liquidia Technologies is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics.

BiopharmaBiotechnologyHealth CareNanotechnologyTherapeutics
Post Ipo EquityApr 13, 2021
Amount Raised: $21,700,000
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsNewsletterPricing

Free tools

Pre-Money and Post-Money Valuation Calculator